$NURO
NeuroMetrix, Inc. Stock $nuro

$nuro Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000162828021007364 Filed on April 22, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$2.155M	$2.172M
YoY Change	-0.76%	-30.45%
Cost Of Revenue	$576.3K	$620.2K
YoY Change	-7.08%	-73.32%
Gross Profit	$1.579M	$1.552M
YoY Change	1.76%	94.3%
Gross Profit Margin	73.26%	71.45%
Selling, General & Admin	$1.406M	$1.676M
YoY Change	-16.11%	-54.01%
% of Gross Profit	89.04%	108.01%
Research & Development	$233.3K	$533.6K
YoY Change	-56.28%	-37.59%
% of Gross Profit	14.77%	34.39%
Depreciation & Amortization	$22.18K	$23.41K
YoY Change	-5.23%	-26.34%
% of Gross Profit	1.4%	1.51%
Operating Expenses	$1.639M	$2.210M
YoY Change	-25.81%	-50.89%
Operating Profit	-$60.20K	-$657.9K
YoY Change	-90.85%	-82.23%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00
YoY Change		-100.0%
Pretax Income	-$60.00K	-$660.0K
YoY Change	-90.91%	-132.2%
Income Tax
% Of Pretax Income
Net Earnings	-$59.78K	-$657.4K
YoY Change	-90.91%	-132.06%
Net Earnings / Revenue	-2.77%	-30.27%
Basic Earnings Per Share	-$0.02	-$0.45
Diluted Earnings Per Share	-$0.02	-$0.45
COMMON SHARES
Basic Shares Outstanding	3.796M shares	1.457M shares
Diluted Shares Outstanding	3.796M shares	1.457M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.150M	$2.820M
YoY Change	82.62%	-60.83%
Cash & Equivalents	$5.100M	$2.816M
Short-Term Investments
Other Short-Term Assets	$360.0K	$340.0K
YoY Change	5.88%	-64.58%
Inventory	$979.6K	$1.154M
Prepaid Expenses
Receivables	$477.7K	$386.1K
Other Receivables	$0.00	$180.0K
Total Short-Term Assets	$6.965M	$4.878M
YoY Change	42.8%	-58.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$182.8K	$250.0K
YoY Change	-26.91%	-33.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$30.00K	$30.00K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$755.5K	$1.329M
YoY Change	-43.14%	-41.64%
TOTAL ASSETS
Total Short-Term Assets	$6.965M	$4.878M
Total Long-Term Assets	$755.5K	$1.329M
Total Assets	$7.721M	$6.206M
YoY Change	24.4%	-55.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$381.2K	$623.2K
YoY Change	-38.82%	11.71%
Accrued Expenses	$605.5K	$1.065M
YoY Change	-43.12%	-64.94%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.088M	$2.882M
YoY Change	-27.55%	-35.99%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$370.0K	$810.0K
YoY Change	-54.32%	-33.06%
Total Long-Term Liabilities	$370.0K	$810.0K
YoY Change	-54.32%	-33.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.088M	$2.882M
Total Long-Term Liabilities	$370.0K	$810.0K
Total Liabilities	$2.460M	$3.692M
YoY Change	-33.38%	-35.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$196.9M	-$195.4M
YoY Change	0.77%	3.4%
Common Stock	$380.00	$168.00
YoY Change	126.19%	-79.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.261M	$2.514M
YoY Change
Total Liabilities & Shareholders Equity	$7.721M	$6.206M
YoY Change	24.4%	-55.37%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	-$59.78K	-$657.4K
YoY Change	-90.91%	-132.06%
Depreciation, Depletion And Amortization	$22.18K	$23.41K
YoY Change	-5.23%	-26.34%
Cash From Operating Activities	-$33.79K	-$763.2K
YoY Change	-95.57%	-281.55%
INVESTING ACTIVITIES
Capital Expenditures	$21.45K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$21.45K	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$25.80K	$453.5K
YoY Change	-105.69%
NET CHANGE
Cash From Operating Activities	-$33.79K	-$763.2K
Cash From Investing Activities	-$21.45K	$0.00
Cash From Financing Activities	-$25.80K	$453.5K
Net Change In Cash	-$81.05K	-$309.7K
YoY Change	-73.83%	-173.68%
FREE CASH FLOW
Cash From Operating Activities	-$33.79K	-$763.2K
Capital Expenditures	$21.45K	$0.00
Free Cash Flow	-$55.24K	-$763.2K
YoY Change	-92.76%	-281.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001289850
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	us-gaap	Substantial Doubt About Going Concern Within One Year SubstantialDoubtAboutGoingConcernWithinOneYear	true
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Woburn
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	001-33351
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	NEUROMETRIX, INC.
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3308180
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4B Gill Street
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01801
CY2021Q1	dei	City Area Code CityAreaCode	781
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	890-9989
CY2021Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2021Q1	dei	Trading Symbol TradingSymbol	NURO
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3803195	shares
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5145167	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5226213	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	477689	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	334297	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	979626	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1051282	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	362921	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	478074	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	6965403	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	7089866	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	182765	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	183494	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	544420	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	692692	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	28284	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	28523	USD
CY2021Q1	us-gaap	Assets Assets	7720872	USD
CY2020Q4	us-gaap	Assets Assets	7994575	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	381248	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	142316	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	605489	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	998442	USD
CY2021Q1	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	535000	USD
CY2020Q4	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	545000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	566256	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	599632	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2087993	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2285390	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	371827	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	461410	USD
CY2021Q1	us-gaap	Liabilities Liabilities	2459820	USD
CY2020Q4	us-gaap	Liabilities Liabilities	2746800	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3796147	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3796147	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3793739	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3793739	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	380	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	379	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	202202254	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	202129195	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-196941583	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-196881800	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	5261052	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5247775	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7720872	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7994575	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2155472	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2172036	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	576289	USD
CY2020Q1	us-gaap	Cost Of Revenue CostOfRevenue	620190	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	1579183	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	1551846	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	233277	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	533620	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	393825	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	424349	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1012276	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1251746	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	1639378	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	2209715	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-60195	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-657869	USD
CY2021Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	412	USD
CY2020Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	498	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-59783	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-657371	USD
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.45
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	2530234	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	144047	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	453457	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	43751	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-657371	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	2514118	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	5247775	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	68863	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	4197	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-59783	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	5261052	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-59783	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-657371	USD
CY2021Q1	us-gaap	Depreciation Depreciation	22182	USD
CY2020Q1	us-gaap	Depreciation Depreciation	23407	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	68863	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	144047	USD
CY2021Q1	nuro	Compensation Obligation Settlement CompensationObligationSettlement	0	USD
CY2020Q1	nuro	Compensation Obligation Settlement CompensationObligationSettlement	43751	USD
CY2021Q1	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	126748	USD
CY2020Q1	nuro	Idle Facility Impairment Charge IdleFacilityImpairmentCharge	87000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	143392	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	87157	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-71656	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-10154	USD
CY2021Q1	nuro	Increase Decrease In Collaboration Receivable IncreaseDecreaseInCollaborationReceivable	0	USD
CY2020Q1	nuro	Increase Decrease In Collaboration Receivable IncreaseDecreaseInCollaborationReceivable	-7678	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	16043	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-312550	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	238932	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-102465	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-332953	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-458772	USD
CY2021Q1	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-10000	USD
CY2020Q1	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-86000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33790	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-763178	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21453	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21453	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	4197	USD
CY2020Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	453457	USD
CY2021Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	30000	USD
CY2020Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-25803	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	453457	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-81046	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-309721	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5226213	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3126206	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5145167	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2816485	USD
CY2021Q1	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	0	USD
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2020Q1	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	43751	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-196900000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5100000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	170683	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y2M12D
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3796120	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1457224	shares
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</span></div>
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-59783	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-657371	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3796120	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1457224	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.45
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	368572	shares
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	206239	shares
CY2021Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	709841	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	716848	USD
CY2021Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	269785	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	334434	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	979626	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1051282	USD
CY2021Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	199000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	343000	USD
CY2021Q1	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	186614	USD
CY2020Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	49837	USD
CY2021Q1	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	1000	USD
CY2020Q4	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	31000	USD
CY2021Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	42700	USD
CY2020Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	49600	USD
CY2021Q1	nuro	Technology Fees TechnologyFees	0	USD
CY2020Q4	nuro	Technology Fees TechnologyFees	450000	USD
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	176175	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	75005	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	605489	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	998442	USD
CY2021Q1	nuro	Accrued Technology Fees Write Off AccruedTechnologyFeesWriteOff	450000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	491369	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	247347	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	165785	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	165785	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	117431	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1187717	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.147
CY2021Q1	nuro	Operating Lease Discount OperatingLeaseDiscount	249634	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	566256	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	371827	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1187717	USD
CY2020Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	166904	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	166904	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y10M24D

Files In Submission

Name	View Source	Status
0001628280-21-007364-index-headers.html	Edgar Link	pending
0001628280-21-007364-index.html	Edgar Link	pending
0001628280-21-007364.txt	Edgar Link	pending
0001628280-21-007364-xbrl.zip	Edgar Link	pending
a10q3312021ex311.htm	Edgar Link	pending
a10q3312021ex312.htm	Edgar Link	pending
a10q3312021ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nuro-20210331.htm	Edgar Link	pending
nuro-20210331.xsd	Edgar Link	pending
nuro-20210331_cal.xml	Edgar Link	unprocessable
nuro-20210331_def.xml	Edgar Link	unprocessable
nuro-20210331_htm.xml	Edgar Link	completed
nuro-20210331_lab.xml	Edgar Link	unprocessable
nuro-20210331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NURO
NeuroMetrix, Inc. Stock $nuro

2021 Q1 Form 10-Q Financial Statement

#000162828021007364 Filed on April 22, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO NeuroMetrix, Inc. Stock $nuro

2021 Q1 Form 10-Q Financial Statement

#000162828021007364 Filed on April 22, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO
NeuroMetrix, Inc. Stock $nuro